vs

Side-by-side financial comparison of HUTCHMED (China) Ltd (HCM) and PHOTRONICS INC (PLAB). Click either name above to swap in a different company.

HUTCHMED (China) Ltd is the larger business by last-quarter revenue ($270.8M vs $210.4M, roughly 1.3× PHOTRONICS INC). PHOTRONICS INC runs the higher net margin — 10.9% vs 0.7%, a 10.2% gap on every dollar of revenue. On growth, PHOTRONICS INC posted the faster year-over-year revenue change (-5.5% vs -16.5%). PHOTRONICS INC produced more free cash flow last quarter ($25.2M vs $3.4M).

HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.

Photronics, Inc. is an American semiconductor photomask manufacturer. It was the third largest photomask supplier globally as of 2009. Photronics is a member of the eBeam Initiative.

HCM vs PLAB — Head-to-Head

Bigger by revenue
HCM
HCM
1.3× larger
HCM
$270.8M
$210.4M
PLAB
Growing faster (revenue YoY)
PLAB
PLAB
+11.0% gap
PLAB
-5.5%
-16.5%
HCM
Higher net margin
PLAB
PLAB
10.2% more per $
PLAB
10.9%
0.7%
HCM
More free cash flow
PLAB
PLAB
$21.9M more FCF
PLAB
$25.2M
$3.4M
HCM

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
HCM
HCM
PLAB
PLAB
Revenue
$270.8M
$210.4M
Net Profit
$2.0M
$22.9M
Gross Margin
37.7%
33.7%
Operating Margin
-13.2%
22.9%
Net Margin
0.7%
10.9%
Revenue YoY
-16.5%
-5.5%
Net Profit YoY
-83.6%
-32.4%
EPS (diluted)
$0.00
$0.39

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HCM
HCM
PLAB
PLAB
Q4 25
$270.8M
Q3 25
$210.4M
Q2 25
$277.7M
$211.0M
Q1 25
$324.5M
$212.1M
Q4 24
$222.6M
Q3 24
$211.0M
Q2 24
$305.7M
$217.0M
Q1 24
$216.3M
Net Profit
HCM
HCM
PLAB
PLAB
Q4 25
$2.0M
Q3 25
$22.9M
Q2 25
$455.0M
$8.9M
Q1 25
$11.9M
$42.9M
Q4 24
$33.9M
Q3 24
$34.4M
Q2 24
$25.8M
$36.3M
Q1 24
$26.2M
Gross Margin
HCM
HCM
PLAB
PLAB
Q4 25
37.7%
Q3 25
33.7%
Q2 25
0.1%
36.9%
Q1 25
48.0%
35.6%
Q4 24
37.0%
Q3 24
35.6%
Q2 24
41.1%
36.5%
Q1 24
36.6%
Operating Margin
HCM
HCM
PLAB
PLAB
Q4 25
-13.2%
Q3 25
22.9%
Q2 25
-1.3%
26.4%
Q1 25
-5.0%
24.6%
Q4 24
25.1%
Q3 24
24.7%
Q2 24
-9.0%
25.8%
Q1 24
26.6%
Net Margin
HCM
HCM
PLAB
PLAB
Q4 25
0.7%
Q3 25
10.9%
Q2 25
163.8%
4.2%
Q1 25
3.7%
20.2%
Q4 24
15.2%
Q3 24
16.3%
Q2 24
8.4%
16.7%
Q1 24
12.1%
EPS (diluted)
HCM
HCM
PLAB
PLAB
Q4 25
$0.00
Q3 25
$0.39
Q2 25
$0.52
$0.15
Q1 25
$0.01
$0.68
Q4 24
$0.54
Q3 24
$0.55
Q2 24
$0.03
$0.58
Q1 24
$0.42

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HCM
HCM
PLAB
PLAB
Cash + ST InvestmentsLiquidity on hand
$1.4B
$575.8M
Total DebtLower is stronger
$93.2M
$16.0K
Stockholders' EquityBook value
$1.2B
$1.1B
Total Assets
$1.8B
$1.8B
Debt / EquityLower = less leverage
0.08×
0.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HCM
HCM
PLAB
PLAB
Q4 25
$1.4B
Q3 25
$575.8M
Q2 25
$1.4B
$558.4M
Q1 25
$836.1M
$642.2M
Q4 24
$640.7M
Q3 24
$606.4M
Q2 24
$802.5M
$559.9M
Q1 24
$521.5M
Total Debt
HCM
HCM
PLAB
PLAB
Q4 25
$93.2M
Q3 25
$16.0K
Q2 25
$93.4M
$19.0K
Q1 25
$82.8M
$21.0K
Q4 24
$25.0K
Q3 24
$28.0K
Q2 24
$82.1M
$2.5M
Q1 24
$2.7M
Stockholders' Equity
HCM
HCM
PLAB
PLAB
Q4 25
$1.2B
Q3 25
$1.1B
Q2 25
$1.2B
$1.1B
Q1 25
$759.9M
$1.1B
Q4 24
$1.1B
Q3 24
$1.1B
Q2 24
$740.1M
$1.0B
Q1 24
$1.0B
Total Assets
HCM
HCM
PLAB
PLAB
Q4 25
$1.8B
Q3 25
$1.8B
Q2 25
$1.8B
$1.7B
Q1 25
$1.3B
$1.7B
Q4 24
$1.7B
Q3 24
$1.6B
Q2 24
$1.3B
$1.6B
Q1 24
$1.6B
Debt / Equity
HCM
HCM
PLAB
PLAB
Q4 25
0.08×
Q3 25
0.00×
Q2 25
0.08×
0.00×
Q1 25
0.11×
0.00×
Q4 24
0.00×
Q3 24
0.00×
Q2 24
0.11×
0.00×
Q1 24
0.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HCM
HCM
PLAB
PLAB
Operating Cash FlowLast quarter
$8.2M
$50.1M
Free Cash FlowOCF − Capex
$3.4M
$25.2M
FCF MarginFCF / Revenue
1.2%
12.0%
Capex IntensityCapex / Revenue
1.8%
11.8%
Cash ConversionOCF / Net Profit
4.21×
2.19×
TTM Free Cash FlowTrailing 4 quarters
$-96.2M
$64.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HCM
HCM
PLAB
PLAB
Q4 25
$8.2M
Q3 25
$50.1M
Q2 25
$-72.9M
$31.5M
Q1 25
$40.3M
$78.5M
Q4 24
$68.4M
Q3 24
$75.1M
Q2 24
$-39.8M
$76.5M
Q1 24
$41.5M
Free Cash Flow
HCM
HCM
PLAB
PLAB
Q4 25
$3.4M
Q3 25
$25.2M
Q2 25
$-82.2M
$-29.1M
Q1 25
$32.5M
$43.3M
Q4 24
$25.2M
Q3 24
$50.7M
Q2 24
$-49.9M
$56.5M
Q1 24
$-1.8M
FCF Margin
HCM
HCM
PLAB
PLAB
Q4 25
1.2%
Q3 25
12.0%
Q2 25
-29.6%
-13.8%
Q1 25
10.0%
20.4%
Q4 24
11.3%
Q3 24
24.0%
Q2 24
-16.3%
26.0%
Q1 24
-0.8%
Capex Intensity
HCM
HCM
PLAB
PLAB
Q4 25
1.8%
Q3 25
11.8%
Q2 25
3.3%
28.7%
Q1 25
2.4%
16.6%
Q4 24
19.4%
Q3 24
11.6%
Q2 24
3.3%
9.2%
Q1 24
20.0%
Cash Conversion
HCM
HCM
PLAB
PLAB
Q4 25
4.21×
Q3 25
2.19×
Q2 25
-0.16×
3.55×
Q1 25
3.38×
1.83×
Q4 24
2.02×
Q3 24
2.18×
Q2 24
-1.54×
2.11×
Q1 24
1.59×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HCM
HCM

Segment breakdown not available.

PLAB
PLAB

High End Integrated Circuits$53.6M25%
High End Flat Panel Displays$53.5M25%
KR$43.7M21%
Other$42.1M20%
Mainstream Flat Panel Displays$9.1M4%
Transferred At Point In Time$8.4M4%

Related Comparisons